SOD1 and myeloid sarcoma: The negative association between antioxidant responses (SOD1 and GSTP1 secretion) and duration of progressive MS raises the possibility that chronic exposure to disease adversely affects MSC function with functional consequences for the bone marrow microenvironment including, for example, alterations in regulatory and pro‐inflammatory T‐cell populations.